Basic Characteristics of Oligodendrogliomas: The Shohada-e Tajrish Hospital Experience (2008-2014)

Publish Year: 1396
نوع سند: مقاله ژورنالی
زبان: English
View: 382

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJP-12-3_008

تاریخ نمایه سازی: 1 مهر 1398

Abstract:

Background and Objectives: Gliomas are the most prevalent subgroup of primary brain tumors with a relatively high mortality. However, oligodendrogliomas have a better prognosis compared to other subtypes due to their sensitivity to chemotherapy. Considering the low incidence and the resulting lack of information about oligodendrogliomas, particularly in Iran, this study aimed at assessing their basic characteristics. Methods:In this descriptive retrospective study, patients with definite diagnosis of oligodendroglioma were identified by reviewing the archives of pathology reports at the department of pathology of Shohada-e Tajrish Hospital during years 2008 to 2014. Age, gender, location, and the grade of the tumor were extracted and entered to the SPSS statistical software for analysis. Results: A total of 182 patients, including 115 males (63.2%) and 67 females (36.8%), were included with a mean age of 38.5±13.36 years. Frontal lobe was involved in 53 patients (29.1%), parietal lobe in 31 (17.0%), temporal lobe in 22 (12.1%), frontoparietal area in 15 (8.2%), parieto-occipital area in 11 (6.0%), temporoparietal and frontotemporal areas each in 9 subjects (4.9%), occipital lobe in 5 (2.7%), and the brainstem in 4 (2.2%). Furthermore, 108 cases (59.3%) had grade-2 and the remaining74 patients (40.7%) had grade-3 anaplastic oligodendrogliomas. The mean age of subjects with brainstem oligodendrogliomas was significantly lower than the other patients (p=0.025). Conclusion: Oligodendrogliomas commonly effects the frontal lobe, followed by the parietal and temporal lobes. The mean age of subjects with brainstem lesions was significantly lower than other patients. Age, gender or location of the tumor did not independently predict a higher grade lesion.

Authors

Mahsa Ahadi

Cancer Research Center, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Afshin Moradi

Cancer Research Center, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Azadeh Rakhshan

Cancer Research Center, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Alireza Arefian

Cancer Research Center, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Allison RR, Schulsinger A, Vongtama V, Barry T, Shin KH. ...
  • Karim AB, Afra D, Cornu P, Bleehan N, Schraub S, ...
  • Ellis TL, Stieber VW, Austin RC. Oligodendroglioma. Curr Treat Options ...
  • Engelhard HH, Stelea A, Mundt A. Oligodendroglioma and anaplastic oligodendroglioma:: ...
  • Van den Bent M, Taphoorn M, Brandes Aa, Menten J, ...
  • Fleury A, Menegoz F, Grosclaude P, Daures JP, Henry‐Amar M, ...
  • Van den Bent M. Advances in the biology and treatment ...
  • Hashimoto N, Murakami M, Takahashi Y, Fujimoto M, Inazawa J, ...
  • Jacob R, Jyothirmayi R, Dalal Y, Nambiar U, Rajan B, ...
  • HELSETH A, MØRK SJ, JOHANSEN A, TRETLI S. Neoplasms of ...
  • Nutt CL, Mani D, Betensky RA, Tamayo P, Cairncross JG, ...
  • Peterson K, Cairncross JG. Oligoden-droglioma. Cancer Invest. 1996;14(3):243-51. ...
  • Kleihues P, Cavenee WK. Pathology and genetics of tumours of ...
  • Celli P, Nofrone I, Palma L, Cantore G, Fortuna A. ...
  • Daumas-Duport C, Varlet P, Tucker M-L, Beuvon F, Cervera P, ...
  • Engelhard HH, Stelea A, Cochran EJ. Oligodendroglioma: pathology and molecular ...
  • Paleologos NA, Cairncross JG. Treatment of oligodendroglioma: an update. Neuro ...
  • Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, ...
  • Feigenberg SJ, Amdur RJ, Morris CG, Mendenhall WM, Marcus Jr ...
  • Fortin D, Cairncross GJ, Hammond RR. Oligodendroglioma: an appraisal of ...
  • Sunyach M, Pommier P, Lafay IM, Guyotat J, Ginestet G, ...
  • Shaw EG, Scheithauer BW, O Fallon JR, Tazelaar HD, Davis ...
  • SPSS I. IBM SPSS statistics 22. Algorithms Chicago: IBM SPSS ...
  • Nielsen MS, Christensen HC, Kosteljanetz M, Johansen C. Incidence of ...
  • Mørk SJ, Lindegaard K-F, Halvorsen TB, Lehmann EH, Solgaard T, ...
  • Chin HW, Hazel JJ, Kim TH, Webster JH. Oligodendrogliomas I. ...
  • Reyes-Botero G, Mokhtari K, Martin-Duverneuil N, Delattre J-Y, Laigle-Donadey F. ...
  • نمایش کامل مراجع